The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, supporting its future growth.The U.S. Meals and Drug...
From left: Katherine Mast Hagemann, B.S.N., RN, and Dr. Andrew KuykendallThe present atmosphere in oncology (and medication on the whole) incentivizes hurried, impersonal...
